Shantanu Narayen, a reporting person for Pfizer Inc [PFE], has engaged in a transaction involving the company's stock. The action took place on September 30, 2024. However, the specific details regarding the nature of the transaction, such as the action type, status, number of shares involved, transaction price, and the resulting ownership stake, have not been disclosed. This information is critical for investors to understand the implications of the transaction on their investment decisions.

Shantanu Narayen, a reporting person for Pfizer Inc [PFE], has engaged in a transaction involving the company's stock. The action took place on September 30, 2024. However, the specific details regarding the nature of the transaction, such as the action type, status, number of shares involved, transaction price, and the resulting ownership stake, have not been disclosed. This information is critical for investors to understand the implications of the transaction on their investment decisions.